In this articleESALY4523.T-JPBIIBHannah Yoon | The Washington Post | Getty ImagesLeqembi, an Alzheimer's drug from Biogen and Eisai, isn't a cure for the mind-damaging disease. But the treatment promises to give patients such as Missie Meeks more time to live their daily lives normally and independently of others.Meeks, an English professor based in Ellisville, Mississippi, was diagnosed with an early stage of Alzheimer's last summer ahead of her 50th birthday. That eventually made her a good fit for Leqemb ...